Clinical Trials in Dallas

Showing 6881-6900 of 17,468 trials

A Study of PRT2527 in Participants With Advanced Solid Tumors

NCT05159518

This is a Phase 1 dose-escalation and confirmation study of PRT2527, a Cyclin-dependent Kinase 9 (CDK9) inhibitor, in participants with advanced solid tumors. The purpose of this study is to define the dosing schedule, and maximally tolerated dose to be used in subsequent development of PRT2527.

SarcomaCastrate Resistant Prostate CancerHormone Receptor Positive HER2 Negative Breast Cancer+2 more

Prelude Therapeutics30 participantsStarted Feb 2022

Denver, Colorado, United States • Celebration, Florida, United States • Sarasota, Florida, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

NCT03905330

The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric participants with Progressive Familial Intrahepatic Cholestasis (PFIC).

Progressive Familial Intrahepatic Cholestasis (PFIC)

Mirum Pharmaceuticals, Inc.93 participantsStarted Jul 2019

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Orlando, Florida, United States +28 more locations

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Find Trials by Condition in Dallas

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Approaches and Decisions for Acute Pediatric TBI Trial

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma

Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee

Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

Examine the Psychosocial Impacts of COVID-19 Pandemic.

International Lung Screen Trial (ILST)